PAUL PERREAULT is CEO and Managing Director of
CSL Behring. Previously having served as its president,
he was responsible for overseeing operations in more
than 25 countries, including major manufacturing
sites in the United States, Switzerland, Germany and
Australia, and an extensive network of plasma collection centers throughout North America and Germany.
Prior to this, he was Executive Vice President, World-
wide Commercial Operations with responsibility for
all commercial and business development activities
globally for CSL Behring.
Mr. Perreault has also held several executive positions at
Aventis Behring, including Vice President and General
Manager of Plasma Operations at Aventis Bio-Services,
and Vice President and General Manager for Aventis Behring Hospital Products in North America and
Puerto Rico. Click on the image for audio of his keynote
address at eyeforpharma Philadelphia on May 2, 2016.